stockportfolio.pro
Stocks / ATEC vs COAG
ATEC vs COAG
Alphatec Holdings, Inc. and Hemab Therapeutics Holdings, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Alphatec Holdings, Inc. (ATEC) | Hemab Therapeutics Holdings, Inc. (COAG) | |
|---|---|---|
| Market cap | $1.3B | $1.2B |
| Revenue (latest FY) | $764.15M | $0 |
| Net income (latest FY) | $-143.36M | $-63.91M |
| Revenue growth (5y CAGR) | 39.5% | — |
| Net margin | -18.8% | — |
| Return on equity | -1153.8% | 36.2% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | No | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ATEC — free Open COAG — freeFrequently asked questions
Which is bigger, ATEC or COAG?
Alphatec Holdings, Inc. is larger by market capitalization — $1.3B versus $1.2B.
Which grows faster, ATEC or COAG?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.